Page last updated: 2024-08-26

paxilline and pyrogallol

paxilline has been researched along with pyrogallol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elbling, L; Fiebiger, E; Gerner, C; Jäger, W; Kunstfeld, R; Mikula, M; Paulitschke, V; Pehamberger, H; Riemer, AB; Scheiner, O; Schicher, N; Swoboda, A; Szekeres, T; Trimurtulu, G; Venkateswarlu, S	1

Other Studies

1 other study(ies) available for paxilline and pyrogallol

Article	Year
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. The Journal of investigative dermatology, 2010, Volume: 130, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Disease Progression; DNA Damage; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Mice; Mice, SCID; Paxillin; Pyrogallol; Skin Neoplasms; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2010

Article

Year

3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.

The Journal of investigative dermatology, 2010, Volume: 130, Issue:6

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Disease Progression; DNA Damage; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Mice; Mice, SCID; Paxillin; Pyrogallol; Skin Neoplasms; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2010